已收盤 02-06 16:00:00 美东时间
+0.220
+2.49%
Barrington Research analyst Patrick Sholl maintains Lionsgate Studios (NYSE:LION) with a Outperform and maintains $11.5 price target.
02-06 20:53
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
2025-11-25 10:27
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 10:22
Lionsgate, Virtual Brand Group (VBG), and Super League have launched "The Strangers: Chapter 2" in five Roblox games, offering an immersive survival experience for Halloween. Players face masked killers Pinup Girl, Scarecrow, and Dollface in escape-room-style challenges. Fans can unlock exclusive rewards and virtual items through the Lionsgate virtual Movie Store and PopMall. This collaboration merges cinematic horror with interactive gaming, cre...
2025-10-20 13:00
MiNK Therapeutics, Inc.涨730.1%;Above Food Ingredients Inc. Ordinary Shares涨134.2%;新蛋涨71.4%
2025-07-12 09:24
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1137304602125590529.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Wolfe Research:维持Cheche Group(CCG)"跑赢大市"评级,目标价从335美元升至350美元</p> <p>• HC Wainwright & Co.:上调AnaptysBio(ANAB)
2025-06-05 09:42
潜在涨幅746.15%!Intrusion获Ascendiant Capital升目标价至11美元,维持"买入"评级
2025-06-02 13:32
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通:维持Cogent Biosciences(COGT)"超配"评级,目标价从21美元升至25美元</p> <p>• Chardan Capital:维持Taysha Gene Therapies(TSHA)"买入"
2025-05-30 09:09
潜在涨幅1562.13%!Cingulate获Ascendiant Capital升目标价至61美元,维持"买入"评级
2025-05-28 09:04